Related references
Note: Only part of the references are listed.Personal (Self) Perceptions of Submental Fat Among Adults in the United States
Leslie Baumann et al.
DERMATOLOGIC SURGERY (2019)
Noninvasive Body Contouring A Male Perspective
Heidi Wat et al.
DERMATOLOGIC CLINICS (2018)
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H. Jones et al.
DERMATOLOGIC SURGERY (2016)
ATX-101 for reduction of submental fat: A phase III randomized controlled trial
Shannon Humphrey et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Results from a Pooled Analysis of Two European, Randomized, Placebo-Controlled, Phase 3 Studies of ATX-101 for the Pharmacologic Reduction of Excess Submental Fat
James McDiarmid et al.
AESTHETIC PLASTIC SURGERY (2014)
Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study
B. Rzany et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study
B. Ascher et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Measuring Patient-Reported Outcomes in Facial Aesthetic Patients: Development of the FACE-Q
Anne F. Klassen et al.
FACIAL PLASTIC SURGERY (2010)
Share Paper
